Clinical trial
Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent…
NCT00230230 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00230230 |
|---|---|
| Title | Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED) |
| Official title | SCH 486757 vs Codeine and Placebo in Subjects With Persistent Postviral Cough |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cough |
| Intervention type | Drug |
| Interventions | SCH 486757 |
| Enrollment | 91 |
| Start date | Oct 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 30, 2005 |
| Last update posted | Sep 16, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: